nomethiazole sustained-release (sGC-1061)
/ sGC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 03, 2013
Study confirms potential of new class of Alzheimer's drugs
(PRNewswire)
- "Administration of sGC-1061...to E4FAD mice for 10 weeks resulted in a significant reduction in the levels of soluble (neurotoxic) amyloid-beta (amino acids 1-42) in the treated animals. Previous published studies on sGC -1061 have demonstrated...sGC-1061 is poised to enter phase 2 evaluation in target populations."
Anticipated new P2 trial • Preclinical • Alzheimer's Disease
1 to 1
Of
1
Go to page
1